Home

Pflug Genesen Format psa 0.008 Selten Blauwal Explizit

Integrated formulas to forecast prostate cancer: the parameters of  influencing the prostate specific antigen level as an adjunct to prostate  specific antigen and multi-parametric MRI to predict prostate cancer before  biopsy -
Integrated formulas to forecast prostate cancer: the parameters of influencing the prostate specific antigen level as an adjunct to prostate specific antigen and multi-parametric MRI to predict prostate cancer before biopsy -

Multivariate regression analysis between serum prostate-specific... |  Download Scientific Diagram
Multivariate regression analysis between serum prostate-specific... | Download Scientific Diagram

The effect of urethral catheterization on the level of prostate-specific  antigen Izadpanahi MH, Salimi H, Javid A, Eslami S - J Res Med Sci
The effect of urethral catheterization on the level of prostate-specific antigen Izadpanahi MH, Salimi H, Javid A, Eslami S - J Res Med Sci

Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL  and 10 ng/mL. - Abstract - Europe PMC
Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. - Abstract - Europe PMC

Prostate-specific membrane antigen in circulating tumor cells is a new poor  prognostic marker for castration-resistant prostate cancer | PLOS ONE
Prostate-specific membrane antigen in circulating tumor cells is a new poor prognostic marker for castration-resistant prostate cancer | PLOS ONE

Treatment strategy for metastatic prostate cancer with extremely high PSA  level: reconsidering the value of vintage therapy | Semantic Scholar
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy | Semantic Scholar

Cancers | Free Full-Text | PSA and PSA Kinetics Thresholds for the Presence  of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical  Recurrent Prostate Cancer
Cancers | Free Full-Text | PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer

Measurement of total and free prostate specific antigen (PSA) in human  serum samples using an ultra-microanalytical system - ScienceDirect
Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect

Impact of nadir PSA level and time to nadir during initial androgen  deprivation therapy on prognosis in patients with metastatic  castration-resistant prostate cancer | SpringerLink
Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer | SpringerLink

KoreaMed Synapse
KoreaMed Synapse

Cancers | Free Full-Text | Variables Associated with False-Positive PSA  Results: A Cohort Study with Real-World Data
Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data

Development of a glycoproteomic strategy to detect more aggressive prostate  cancer using lectin-immunoassays for serum fucosylated PSA | Clinical  Proteomics | Full Text
Development of a glycoproteomic strategy to detect more aggressive prostate cancer using lectin-immunoassays for serum fucosylated PSA | Clinical Proteomics | Full Text

Kaplan-Meier survival curves of (a) PSA-progression-fre | Open-i
Kaplan-Meier survival curves of (a) PSA-progression-fre | Open-i

I'm officially 4-years NED, undetectable PSA! - Gogs Gagnon
I'm officially 4-years NED, undetectable PSA! - Gogs Gagnon

Efficacy of Androgen Deprivation Therapy for Localized Prostate Cancer:  Analysis of pT0 Evaluated by Radical Prostatectomy Speci
Efficacy of Androgen Deprivation Therapy for Localized Prostate Cancer: Analysis of pT0 Evaluated by Radical Prostatectomy Speci

Outcomes of salvage radiotherapy for recurrent prostate cancer after  radical prostatectomy | HKMJ
Outcomes of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy | HKMJ

Outcomes of salvage radiotherapy for recurrent prostate cancer after  radical prostatectomy | HKMJ
Outcomes of salvage radiotherapy for recurrent prostate cancer after radical prostatectomy | HKMJ

Usefulness of ultra‑sensitive prostate‑specific antigen following radical  prostatectomy
Usefulness of ultra‑sensitive prostate‑specific antigen following radical prostatectomy

Early prostate-specific antigen (PSA) response or progression and survival  | Download Table
Early prostate-specific antigen (PSA) response or progression and survival | Download Table

Frontiers | Pathological characteristics and predictive factors of prostate  biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml
Frontiers | Pathological characteristics and predictive factors of prostate biopsy in patients with serum PSA levels between 0 and 4.0 ng/ml